Morana Jovan-Embiricos, Director, 10% Owner at TCR2 THERAPEUTICS INC. (TCRR), bought 500,000 shares at $15.00 ($7.5M) on 2019-02-19, disclosed to the SEC on 2019-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 133,333 | $2.0M | 26.7% |
| 2 | $15.00 | 166,667 | $2.5M | 33.3% |
| 3 | $15.00 | 200,000 | $3.0M | 40.0% |
| Total | $15.00 avg | 500,000 | $7.5M | 100% |
| Filing → |
| ALVR | SELL | 2021-11-09 | $559K | — | Filing → |
| ALVR | SELL | 2021-10-29 | $55K | — | Filing → |
| ALVR | SELL | 2021-10-25 | $621K | — | Filing → |